Flavonoids alter P-gp expression in intestinal epithelial cells in vitro and in vivo

被引:46
|
作者
Lohner, Katrin
Schnaebele, Kerstin
Daniel, Hannelore
Oesterle, Doris
Rechkemmer, Gerhard
Goettlicher, Martin
Wenzel, Uwe
机构
[1] Univ Giessen, Interdisciplinary Res Ctr, D-35392 Giessen, Germany
[2] Tech Univ Munich, Dept Food & Nutr, Mol Nutr Unit, Freising Weihenstephan, Germany
[3] GSF, Inst Toxicol, Neuherberg, Germany
关键词
C57BL; Caco-2 human intestinal epithelial cells; flavonoids; flow cytometry; P-glycoprotein expression;
D O I
10.1002/mnfr.200600225
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Flavonoids are secondary plant metabolites included in our diet but are also provided in a growing number of supplements. They are suggested to interact with intestinal transport systems including phospbo-glycoprotein (P-gp) which mediates the efflux of a variety of xenobiotics back into the gut lumen. In human intestinal Caco-2 cells, we tested the effects of 14 different flavonoids on P-gp expression in vitro. Protein expression levels were quantified by Western blotting, flow cytometry, and real-time PCR. Except apigenin, all flavonoids at concentrations of 10 mu M increased P-gp expression in Western blotting experiments when cells were exposed to the compounds over 4 wk. Flavone was one of the most effective P-gp inducers in Caco-2 cells and its effects were, therefore, also assessed for changes in P-gp in vivo in the gastrointestinal tract of C57BL/6 mice. P-gp expression was significantly increased by flavone (400 mg/kg body weight x day over 4 wk) in the small intestine but not in the colon which displayed intrinsically the highest expression level. In conclusion, the increase in P-gp expression caused by flavonoids in intestinal epithelial cells in vitro and also in vivo may serve as an adaptation and defense mechanism limiting the entry of lipophilic xenobiotics into the organism.
引用
收藏
页码:293 / 300
页数:8
相关论文
共 50 条
  • [41] P-gP and MRP immunostaining in gliomas - does the expression of P-gP and MRP correlate with chemosensitivity in glioma cell cultures?
    Sutton, C.
    Ashton, K.
    Dawson, T. P.
    BRAIN PATHOLOGY, 2010, 20 : 55 - 56
  • [42] Psoriasin expression in mammary epithelial cells in vitro and in vivo
    Enerbäck, C
    Porter, DA
    Seth, P
    Sgroi, D
    Gaudet, J
    Weremowicz, S
    Morton, CC
    Schnitt, S
    Pitts, RI
    Stampl, J
    Barnhart, K
    Polyak, K
    CANCER RESEARCH, 2002, 62 (01) : 43 - 47
  • [43] Intestinal P-glycoprotein (P-gp) Contribution to Talinolol Pharmacokinetics in Human
    Wan, Christine
    Ishida, Kazuya
    Lai, Yurong
    FASEB JOURNAL, 2022, 36
  • [44] The immune-expression of P-gp in uveal melanoma cell lines in vitro and animal model
    Filho, JPS
    Caissie, AL
    Blanco, PL
    Callejo, SA
    Cools-Laritgue, J
    Vianna, RNG
    Burnier, MN
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U515 - U515
  • [45] Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318
    Chen, LM
    Liang, YJ
    Ruan, JW
    Ding, Y
    Wang, XW
    Shi, Z
    Gu, LQ
    Yang, XP
    Fu, LW
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2004, 56 (08) : 1061 - 1066
  • [46] P-GP REGULATES APOPTOSIS IN GASTRIC MUCOSA BY INTERACTING WITH BCL-XL: AN IN VIVO AND IN VITRO STUDY
    Rocco, A.
    Compare, D.
    Liguori, E.
    D'Armiento, M.
    Staibano, S.
    Sica, M.
    Ferrara, V.
    Nardone, O. M.
    Zamparelli, M. Sanduzzi
    Garbi, C.
    Avvedimento, V. E.
    Nardone, G.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 : S126 - S126
  • [47] IN VITRO P-GP EFFLUX RATIO CAN PREDICT THE IN VIVO BRAIN PENETRATION REGARDLESS OF BDDCS CLASS
    Kalvass, J. Cory
    Kikuchi, Ryota
    de Morais, Sonia M.
    DRUG METABOLISM REVIEWS, 2014, 45 : 57 - 57
  • [48] Effects of Kampo medicines on CYP and P-gp activity in vitro
    Ito, Kiyomi
    Satoh, Toshiyuki
    Watanabe, Yuka
    Ikarashi, Nobutomo
    Asano, Takayuki
    Morita, Toshimi
    Sugiyama, Kiyoshi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (05) : 893 - 896
  • [49] The anti-hepatitis drug DDB chemosensitizes multidrug resistant cancer cells in vitro and in vivo by inhibiting P-gp and enhancing apoptosis
    Jing Jin
    Hua Sun
    Huailing Wei
    Gengtao Liu
    Investigational New Drugs, 2007, 25 : 95 - 105
  • [50] The anti-hepatitis drug DDB chemosensitizes multidrug resistant cancer cells in vitro and in vivo by inhibiting P-gp and enhancing apoptosis
    Jin, g Jin
    Sun, Hua
    Wei, Huailing
    Liu, Gengtao
    INVESTIGATIONAL NEW DRUGS, 2007, 25 (02) : 95 - 105